These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1126760)

  • 1. Cell-mediated cytotoxicity to human pulmonary neoplasms.
    Vose BM; Moore M; Jack GD
    Int J Cancer; 1975 Feb; 15(2):308-20. PubMed ID: 1126760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of surgery on tumour-directed leucocyte responses.
    Vose BM; Moudgil GC
    Br Med J; 1975 Jan; 1(5949):56-8. PubMed ID: 1109658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular immunity to renal carcinomas in man.
    Bubeník J; Jakoubková J; Krákora P; Baresová M; Helbich P; Viklický V; Malasková V
    Int J Cancer; 1971 Nov; 8(3):503-13. PubMed ID: 5137312
    [No Abstract]   [Full Text] [Related]  

  • 4. Cell-mediated and humoral immune reactions to human tumours.
    Baldwin RW; Embleton MJ; Jones JS; Langman MJ
    Int J Cancer; 1973 Jul; 12(1):73-83. PubMed ID: 4790710
    [No Abstract]   [Full Text] [Related]  

  • 5. Cell-mediated cytotoxicity against human bladder cancer.
    Bloom ET; Ossorio RC; Brosman SA
    Int J Cancer; 1974 Sep; 14(3):326-34. PubMed ID: 4477556
    [No Abstract]   [Full Text] [Related]  

  • 6. Leucocytotoxicity in malignant and non-malignant colonic diseases.
    Vose BM; Moore M; Schofield PF; Dymock IW
    Clin Exp Immunol; 1975 Dec; 22(3):393-8. PubMed ID: 1225484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukocyte adherence inhibition assay in human pulmonary neoplasia.
    Kotlar HK; Eker P; Brennhovd I; Høst H; Høie J; Sanner T
    Eur J Cancer Clin Oncol; 1982 Feb; 18(2):141-6. PubMed ID: 7047165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demonstration of tumor-specific antigen in squamous cell carcinomas of the lung, using an established bronchial carcinoma line E 14. Short communication.
    Auchmann M; Breit P; Cerni C; Micksche M; Vetterlein M; Wrba H
    Osterr Z Onkol; 1974; (1):26-8. PubMed ID: 4480616
    [No Abstract]   [Full Text] [Related]  

  • 9. Sensitization to tumour-associated antigens in human breast carcinoma.
    Cochran AJ; Grant RM; Spilg WG; Mackie RM; Ross CE; Hoyle DE; Russell JM
    Int J Cancer; 1974 Jul; 14(1):19-25. PubMed ID: 4617707
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of migration of human autogenous and allogeneic leukocytes by extracts of patients' cancers.
    Wolberg WH
    Cancer Res; 1971 Jun; 31(6):798-802. PubMed ID: 4326036
    [No Abstract]   [Full Text] [Related]  

  • 11. Lack of correlation between carcinoembryonic antigen content of tumor extracts and leukocyte migration reactivity of tumor patients.
    Matzku S; Zöller M; Schulz U; Dietze W; Barth HO; Saeger HD; Price MR
    J Natl Cancer Inst; 1980 Jun; 64(6):1345-8. PubMed ID: 6929372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical study of IOT-10 natural killer cells in brain metastases.
    Vaquero J; Coca S; Escandón J; Magallón R; Martínez R
    Acta Neurochir (Wien); 1990; 104(1-2):17-20. PubMed ID: 2166994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of surgery on lymphocyte transformation in patients with cancer.
    Watkins SM
    Clin Exp Immunol; 1973 May; 14(1):69-76. PubMed ID: 4716104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum mucin antigens CASA and MSA in tumors of the breast, ovary, lung, pancreas, bladder, colon, and prostate. A blind trial with 420 patients.
    Devine PL; McGuckin MA; Ramm LE; Ward BG; Pee D; Long S
    Cancer; 1993 Sep; 72(6):2007-15. PubMed ID: 7689923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocyte cytotoxicity against autologous tumour biopsy cells in humans.
    Vose BM; Vanky F; Klein E
    Int J Cancer; 1977 Oct; 20(4):512-9. PubMed ID: 914394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactivity of peripheral blood leukocytes against human foetal cells. II. Cytotoxic potential of preparations enriched or depleted of different leukocyte populations.
    Vose BM; Moore M
    Int J Cancer; 1977 Jan; 19(1):34-42. PubMed ID: 299854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed-hypersensitivity reactions to soluble membrane antigens of human malignant lung cells.
    Hollinshead AC; Stewart TH; Herberman RB
    J Natl Cancer Inst; 1974 Feb; 52(2):327-38. PubMed ID: 4131424
    [No Abstract]   [Full Text] [Related]  

  • 18. [The cellular microenvironment of malignant tumors and its significance in their prognosis].
    Leenman EE; Mukhina MS
    Vopr Onkol; 2013; 59(4):444-52. PubMed ID: 24032217
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunological reactivity in patients with carcinoma of colon.
    Nairn RC; Nind AP; Guli EP; Davies DJ; Rolland JM; McGiven AR; Hughes ES
    Br Med J; 1971 Dec; 4(5789):706-9. PubMed ID: 4943033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactivity of monoclonal antibodies directed against lung cancer antigens with human lung, breast and colon cancer cell lines.
    Schumacher U; Mukthar D; Schenker T
    Dis Markers; 1993 Dec; 11(5-6):225-37. PubMed ID: 8082312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.